XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
Balance at beginning of period at Dec. 31, 2020 $ 235 $ 154,866 $ (62,927) $ (1,200) $ 90,974
Balance at beginning of period (in shares) at Dec. 31, 2020 23,526,517        
Increase (Decrease) in Stockholders' Equity          
Net loss     (29,091)   (29,091)
Unrealized income (loss) on foreign exchange rate translation       190 190
Issuance of common stock under stock compensation plans $ 2 (2)      
Issuance of common stock under stock compensation plans (in shares) 174,000        
Stock-based compensation expense   419     419
Issuance of common stock as compensation   60     60
Issuance of common stock as compensation (in shares) 23,272        
Shares exchanged for taxes on stock-based compensation   (75)     (75)
Shares exchanged for taxes on stock-based compensation (in shares) (31,410)        
Balance at end of period at Dec. 31, 2021 $ 237 155,268 (92,018) (1,010) $ 62,477
Balance at end of period (in shares) at Dec. 31, 2021 23,692,379       23,643,934
Increase (Decrease) in Stockholders' Equity          
Net loss     (20,451)   $ (20,451)
Cash settlement of RSUs   (301)     (301)
Unrealized income (loss) on foreign exchange rate translation       (1,063) (1,063)
Issuance of common stock under stock compensation plans $ 1 (1)      
Issuance of common stock under stock compensation plans (in shares) 155,000        
Stock-based compensation expense   413     413
Treasury Stock Sale   113     113
Shares exchanged for taxes on stock-based compensation   (79)     (79)
Shares exchanged for taxes on stock-based compensation (in shares) (35,050)        
Balance at end of period at Dec. 31, 2022 $ 238 $ 155,413 $ (112,469) $ (2,073) $ 41,109
Balance at end of period (in shares) at Dec. 31, 2022 23,812,329       23,812,329